These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32344180)
21. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma. Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205 [TBL] [Abstract][Full Text] [Related]
22. "Small white sign" in Barrett's esophageal cancer under the squamous epithelium. Hashimoto R; Hirasawa D; Chonan A; Yamaoka H; Nakahori M Gastrointest Endosc; 2017 Jul; 86(1):231-233. PubMed ID: 28012816 [No Abstract] [Full Text] [Related]
23. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Wang Z; Da Silva TG; Jin K; Han X; Ranganathan P; Zhu X; Sanchez-Mejias A; Bai F; Li B; Fei DL; Weaver K; Carpio RV; Moscowitz AE; Koshenkov VP; Sanchez L; Sparling L; Pei XH; Franceschi D; Ribeiro A; Robbins DJ; Livingstone AS; Capobianco AJ Cancer Res; 2014 Nov; 74(21):6364-74. PubMed ID: 25164006 [TBL] [Abstract][Full Text] [Related]
24. Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis. Fels Elliott DR; Perner J; Li X; Symmons MF; Verstak B; Eldridge M; Bower L; O'Donovan M; Gay NJ; ; Fitzgerald RC PLoS Genet; 2017 May; 13(5):e1006808. PubMed ID: 28531216 [TBL] [Abstract][Full Text] [Related]
25. A pilot study of the impact of Vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. Abdel-Latif MMM; Babar M; Kelleher D; Reynolds JV J Cancer Res Ther; 2019; 15(1):185-191. PubMed ID: 30880777 [TBL] [Abstract][Full Text] [Related]
26. LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia. Neyaz A; Odze RD; Rickelt S; Nieman LT; Bledsoe JR; Mahadevan KK; Arora K; Jeck WR; Taylor MS; Gala M; Patil DT; Yilmaz OH; Rivera MN; Ting DT; Deshpande V Clin Transl Gastroenterol; 2020 Dec; 12(1):e00272. PubMed ID: 33464729 [TBL] [Abstract][Full Text] [Related]
27. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma. Wang Q; Ma C; Kemmner W BMC Cancer; 2013 Mar; 13():137. PubMed ID: 23514407 [TBL] [Abstract][Full Text] [Related]
28. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis. Xu JH; Wang YC; Geng X; Li YY; Zhang WM Pathobiology; 2009; 76(1):23-9. PubMed ID: 19188747 [TBL] [Abstract][Full Text] [Related]
30. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma. Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562 [TBL] [Abstract][Full Text] [Related]
31. Esophageal carcinoma originating in the surface epithelium with immunohistochemically proven esophageal gland duct differentiation: A case report. Tamura H; Saiki H; Amano T; Yamamoto M; Hayashi S; Ando H; Doi R; Nishida T; Yamamoto K; Adachi S World J Gastroenterol; 2017 Jun; 23(21):3928-3933. PubMed ID: 28638233 [TBL] [Abstract][Full Text] [Related]
32. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. Koyama S; Maruyama T; Adachi S J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277 [TBL] [Abstract][Full Text] [Related]
33. Survival-associated alternative splicing signatures in esophageal carcinoma. Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323 [TBL] [Abstract][Full Text] [Related]